Incyte Shares Surge on Breakthrough Dermatology Treatment Data () | aktiencheck.de
Incyte Shares Surge on Breakthrough Dermatology Treatment Data Incyte's shares have increased due to the release of compelling clinical trial results for its dermatology treatment Opzelura…